GWI CDMRP Program - FY12 GWI Research Funding Pre-Announcement Released

http://cdmrp.army.mil/pubs/press/2012/12gwirppreann.shtml

NEWS RELEASE

Released: January 27, 2012

Department of Defense Gulf War Illness Research Program
Anticipated Funding Opportunities for Fiscal Year 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness. The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The GWIRP is providing information in this pre-announcement to allow investigators time to plan and develop applications. FY 12 GWIRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February and March 2012. Application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

Mechanism	Eligibility	Key Mechanism Elements	Funding
Investigator-Initiated Research Award	Independent investigators at all academic levels are eligible to apply.	Supports new ideas in basic and clinical developmental research focusing on Gulf War Illness (GWI). Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field. Clinical trials are not allowed under this mechanism.	The maximum allowable funding for the entire period of performance is $600,000 for direct costs. The maximum period of performance is 3 years. More cost-effective studies not requesting the full funding amount are encouraged.
Innovative Treatment Evaluation Award	Independent investigators at all academic levels are eligible to apply.	Supports exploratory or small-scale studies evaluating potential treatments not previously studied in GWI. Pilot Phase II or Phase I/II trial combinations are permitted. Preliminary data are not required, though proposed studies must be supported by logical rationale.	The maximum allowable funding for the entire period of performance is $450,000 for direct costs. The maximum period of performance is 3 years. More cost-effective studies not requesting the full funding amount are encouraged.
Consortium Award	Open only to investigators who received an FY10 GWIRP Consortium Development Award.	Supports a major multi-institutional research effort conducted by leading Gulf War Illness investigators focused on innovative approaches for: identifying treatments improving GWI definition and diagnostics improving GWI definition and diagnostics understanding underlying pathobiology The consortium will consist of a Coordinating Center and multiple Research Sites. May encompass research from basic/ mechanistic to preclinical and clinical studies. A minimum of 3 studies must be submitted as part of the Consortium Award application.	The maximum allowable funding for the entire period of performance is $4,000,000 for direct costs. The Consortium Award will be funded incrementally from FY12 and FY14, assuming availability of congressionally appropriated funds in FY14. The maximum period of performance is 4 years.

All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

Requests for email notification of the release of CDMRP program announcements may be sent to help@cdmrp.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

• CDMRP Public Affairs
  301-619-9783
  CDMRP.PublicAffairs@amedd.army.mil